Mean apnea-hypopnea duration is an independent marker of oxygen desaturation and sleep disruption in OSA patients, beyond the Apnea-Hypopnea Index
In a study of 136 OSA patients, longer mean apnea-hypopnea duration (MAD) was associated with poorer oxygenation, lower average saturation, shorter sleep latency, less NREM3, more NREM1, and higher arousal index. After adjusting for AHI, MAD remained significantly associated with Epworth Sleepiness Scale, sleep latency, NREM1/3, arousal index, and all oxygen metrics, with stronger effects in severe OSA (n=90).
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Mean apnea-hypopnea duration is an independent marker of oxygen desaturation and sleep disruption in OSA patients, beyond the Apnea-Hypopnea Index The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 34/100 (low).
The Claim
Mean apnea-hypopnea duration is an independent marker of oxygen desaturation and sleep disruption in OSA patients, beyond the Apnea-Hypopnea Index
This conclusion is most relevant to: 136 patients with polysomnography-diagnosed obstructive sleep apnea (90 severe, 46 mild-moderate).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸MAD vs. AHI: Sleep patterns, oxygenation among polysomnography diagnosed by OSA patients. (Lung India : official organ of Indian Chest Society, 2026) —
How It Works
The proposed biological pathway:
- ▸Longer apnea-hypopnea events cause more prolonged intermittent hypoxia
- ▸Prolonged hypoxia triggers greater sympathetic activation and arousal responses
- ▸Increased arousals disrupt sleep architecture, reducing NREM3 and increasing NREM1
- ▸Result: Greater oxygen desaturation, sleep fragmentation, and daytime sleepiness
Who Might Benefit
Evidence fit by population:
- ▸136 patients with polysomnography-diagnosed obstructive sleep apnea (90 severe, 46 mild-moderate)
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Observational design cannot establish causality between MAD and outcomes
- ▸Sample size is relatively small (n=136) and limited to a single center, potentially limiting generalizability
Frequently Asked Questions
What is mean apnea-hypopnea duration (MAD)?▼
MAD is the average length of each apnea or hypopnea event during sleep, measured in seconds from polysomnography.
How does MAD differ from AHI in assessing OSA severity?▼
AHI counts the number of events per hour, while MAD measures the duration of each event. This study suggests MAD provides additional information about oxygen desaturation and sleep disruption beyond AHI alone.
Is MAD more important in severe OSA than mild-moderate OSA?▼
Yes, the study found that associations between MAD and sleep/oxygenation metrics were stronger in severe OSA patients (n=90), while in mild-moderate cases only NREM3 duration showed a weak negative correlation.
Could MAD be used to guide OSA treatment decisions?▼
The authors suggest incorporating MAD into routine evaluation may refine patient stratification and guide targeted management strategies, but further research is needed to establish clinical utility.
References
- 1.Varshan LBP, Ayub II, Balasundaram S. “MAD vs. AHI: Sleep patterns, oxygenation among polysomnography diagnosed by OSA patients..” Lung India : official organ of Indian Chest Society, 2026. PMID: 42377158 DOI: 10.4103/lungindia.lungindia_583_25